Gastroenterology Education and CPD for trainees and specialists » Boceprevir Wins FDA Approval to Treat Hepatitis C

- Gastroenterology Education and CPD for trainees and specialists - https://www.gastrotraining.com -

Boceprevir Wins FDA Approval to Treat Hepatitis C

WASHINGTON (MedPage Today) — The FDA has approved the investigational drug boceprevir (Victrelis), in combination with peginterferon and ribavirin, to treat hepatitis C genotype 1, making it the first HCV protease inhibitor to reach market.

Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com